The relationships of "ecstasy" (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory

Human Psychopharmacology

Volumn 26, Issue 7, 2011, Pages 460-469

  Murphy, Philip N ^a   Erwin, Philip G ^a   MacIver, Linda ^a   Fisk, John E ^b   Larkin, Derek ^a   Wareing, Michelle ^c   Montgomery, Catharine ^c   Hilton, Joanne ^a,e   Tames, Frank J ^d   Bradley, Belinda ^b   Yanulevitch, Kate ^a   Ralley, Richard ^a  

^a EDGE HILL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^d UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^e ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

cannabis; ecstasy (MDMA); executive; impairment; memory

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS;

ADULT; ARTICLE; CANNABIS SMOKING; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; INTELLIGENCE; LONG TERM MEMORY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SEMANTIC MEMORY; TASK PERFORMANCE;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; EXECUTIVE FUNCTION; FEMALE; HALLUCINOGENS; HUMANS; MALE; MARIJUANA ABUSE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 80755140560     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1228     Document Type: Article

References (39)

1. Baddeley AD,. 1966. The capacity for generating information by randomization. Q J Exp Psychol 18: 119-129.
2. Buchert R, Thomasius R, Wilke F, et al,. 2004. A voxel-based PET investigation of the long-term effects of 'ecstasy' consumption on brain serotonin transporters. Am J Psychiatry 161: 1181-1189. (Pubitemid 38859166)
3. Cohen J,. 1992. A power primer. Psychol Bull 112: 155-159.
4. Collette F, Hogge M, Salmon E, van der Linden M,. 2006. Exploration of the neural substrates of executive functioning by functional neuroimaging. Neuroscience 139: 209-221.
5. Dafters RI,. 2006. Impulsivity, inhibition and negative priming in ecstasy users. Addict Behav 31: 1436-1441. (Pubitemid 44093851)
6. De Win MML, Jager G, Booij J, et al,. 2008. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain 131: 2936-2945.
7. De Win MML, Jager G, Booij J, et al,. 2008. Neurotoxic effects of ecstasy on the thalamus. Br J Psychiatry 193: 289-296.
8. Eldreth DA, Matochik JA, Cadet JL, Bolla KA,. 2004. Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage 23: 914-920. (Pubitemid 39446525)
9. Faul F, Eerdfelder E,. 1992. GPower: A Priori, Post-Hoc, and Compromise Power Analyses for MS-DOS [computer program]. Dept. of Psychology, University Bonn: Bonn.
10. Fernández-Serrano MJ, Pérez-García M, Schmidt Río-Valle J, Verdejo-García A,. 2010. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. J Psychopharmacol 24: 1317-1332.
11. Fisk JE, Montgomery C,. 2009. Evidence for selective executive function deficits in ecstasy/polydrug users. J Psychopharmacol 23: 40-50.
12. Fisk JE, Montgomery C, Murphy PN, Wareing M,. 2004. Evidence of executive deficits among users of MDMA (ecstasy). Br J Psychol 95: 457-466. (Pubitemid 39594094)
13. Fisk JE, Murphy PN, Montgomery C, Hadjiefthyvoulou F,. 2011. Modelling the adverse effects associated with ecstasy use. Addiction 106: 798-805.
14. Fisk JE, Sharp CA,. 2004. Age-related impairment in executive functioning: updating, inhibition, shifting, and access. J Clin Exp Neuropsychol 26: 874-890. (Pubitemid 39577310)
15. Fisk JE, Warr P,. 1996. Age-related impairment in associative learning: the role of anxiety, arousal, and learning self-efficacy. Pers Indiv Differ 21: 675-686. (Pubitemid 126160518)
16. Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF,. 2006. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology (Berl) 185: 358-368.
17. Jager G, Van Hell HH, De Win MML, et al,. 2007. Effects of frequent cannabis use on hippocampal activity during an associative memory task. Eur Neuropsychophamacol 17: 289-297. (Pubitemid 46156994)
18. Halpern JH, Pope HG, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D,. 2004. Residual neuropsychological effects of illicit 3,4- methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75: 135-147. (Pubitemid 38970121)
19. Hildebrandt H, Brokate B, Eling P, Lanz M,. 2004. Response shifting and inhibition, but not working memory, are impaired after long-term heavy alcohol consumption. Neuropsychol 18: 203-211. (Pubitemid 38520324)
20. Hoare J, Moon D., 2010. Drug misuse declared: findings from the 2009/10 British Crime Survey: England and Wales. Home Office Statistical Bulletin 13/10, London.
21. Klein J, Karaskof T, Koren G,. 2000. Clinical applications of hair testing for drugs of abuseâ the Canadian experience. Forensic Sci Int 107: 281-288. (Pubitemid 30019299)
22. 11C] DASB. Neuropsychopharmacology 30: 1741-1750. (Pubitemid 43086031)
23. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A,. 2000. The unity and diversity of executive functions and their contributions to complex 'frontal lobe' tasks: a latent variable analysis. Cognit Psychol 41: 49-100.
24. Murphy PN, Wareing M, Fisk JE, Montgomery C,. 2009. Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review. Neuropsychobiology 60: 159-175.
25. Nelson HE, Willison J,. 1991. National Adult Reading Test (NART) Test Manual. NFER Nelson: London.
26. Parkes J., 2004. Hair-testing for illicit drugs. The British Journal of Forensic Practice 6: 21-25. (Pubitemid 40071417)
27. Parrott AC,. 2009. Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users. Neuropsychobiology 60: 148-158.
28. Raven J, Raven JC, Court JH,. 1998. Manual for Raven's Progressive Matrices and Vocabulary Scales. Oxford Psychologists Press: Oxford.
29. Salthouse TA, Babcock RL,. 1991. Decomposing adult age differences in working memory. Dev Psychol 27: 763-776.
30. Sarne Y, Mechoulam R,. 2005. Cannabinoids: between neuroprotection and neurotoxicity. CNS Neurol Disord Drug Targets 4: 677-684. (Pubitemid 41782629)
31. Schepis TS, Adinoff B, Rao U,. 2008. Neurobiological processes in adolescent addictive disorders. Am J Addict 17: 6-23. (Pubitemid 351156999)
32. Schweinsburg AD, Brown SA, Tapert SF,. 2008. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev 1: 99-111.
33. Sindicich N, Stafford J, Burns L., 2009. An overview of the 2009 EDRS: the regular ecstasy user survey findings. EDRS Drug Trends Bulletin, December 2009, National Drug and Alcohol Research Centre, University of New South Wales.
34. Soar K, Parrott A, Turner J,. 2009. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users. J Psychopharmacol 23: 745-758.
35. Solowij N, Battisti R,. 2008. The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev 1: 81-98.
36. Substance Abuse and Mental Health Services Administration 2010. Results from the 2009 National Survey on Drug Use and Health: Volume II. Technical Appendices and Selected Prevalence Tables. NSDUH Series H-38B, HHS Publication No. SMA 10-4586 Appendices, Office of Applied Studies: Rockville, MD.
37. Tabachnick BG, Fidell LS,. 2001. Using Multivariate Statistics. Allyn and Bacon: Boston.
38. Verbaten MN,. 2009. Chronic effects of low to moderate alcohol consumption on structural and functional properties of the brain: beneficial or not? Hum Psychopharmacol Clin Exp 24: 199-205.
39. Wareing M, Fisk JE, Murphy PN,. 2000. Working memory deficits in current and previous users of MDMA ('ecstasy'). Br J Psychol 91: 181-188.